http://www.verastem.com
Verastem, Inc. Company Intro
Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on development of medicines to improve the lives of patients diagnosed with cancer.
Industry
Healthcare
Verastem, Inc. Headquaters
117 Kendrick Street
Needham,02494
United States
Verastem, Inc. Share price
08 Aug 2022 09:36 GMT
$1.1200
-0.01 (-0.88 %)
Verastem, Inc. Market cap
$221.77 M
WMC RANKING
2022
Verastem, Inc. # 70
BiotechnologyLatest Verastem, Inc. News
06 Aug 2022
You Should Know These Things About Verastem Inc. (VSTM)
As of Friday close, Verastem Inc.'s (NASDAQ:VSTM) stock was up $0.06, moving up 5.31 percent to $1.19. The average number of shares traded per day over the...
06 Aug 2022
You Should Know These Things About Verastem Inc. (VSTM)
As of Friday close, Verastem Inc.'s (NASDAQ:VSTM) stock was up $0.06, moving up 5.31 percent to $1.19. The average number of shares traded per day over the...
WMC Market Score
WMC Market to Revenue Score
Verastem, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Verastem, Inc. | USD | $84,466 | $88,717 | $-44,767 | $2,218M | 70 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $620,180B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $737,360B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $170,970B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Verastem, Inc. Social Followers vs Top 4 Industry Competitors
Verastem, Inc. Post vs Top 4 Industry Competitors
Verastem, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Verastem, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Verastem, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Verastem, Inc. | 0.92 | 1.25 | 0.02 | 0 | 0 | 0 | 0.57 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 0 | 0 | 0 | 18.78 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 0 | 0 | 0 | 20.12 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
